Gemcitabine Plus S-1 as First-line Chemotherapy in Chinese Patients With Advanced Pancreatic Cancer: A Prospective Study

被引：0
|
作者：
Wu, W. [1 ]
Zheng, Y. [1 ]
Jiang, W. [1 ]
Liu, L. [1 ]
Tong, Z. [1 ]
Zhang, H. [1 ]
Fang, W. [1 ]
Zhao, P. [1 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China
来源：
PANCREAS | 2019年 / 48卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1548 / 1548
页数：1
相关论文
共 50 条
  • [1] Gemcitabine and S-1 as first-line chemotherapy in patients with metastatic or advanced pancreatic cancer.
    Fang, Weijia
    Zhao, Peng
    Zheng, Yi
    Jiang, Weiqin
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [2] Efficacy and safety comparison of nabpaclitaxel plus S-1 and gemcitabine plus S-1 as first-line chemotherapy for metastatic pancreatic cancer
    Xu, Yaolin
    Guo, Xi
    Fan, Yue
    Wang, Dansong
    Wu, Wenchuan
    Wu, Lili
    Liu, Tianshu
    Xu, Bei
    Feng, Yi
    Wang, Yan
    Lou, Wenhui
    Zhou, Yuhong
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (06) : 535 - 541
  • [3] Comparing the Efficacy of Nab-paclitaxel Plus S-1 With Gemcitabine-based Chemotherapy as First-line Strategy for Advanced Pancreatic Cancer
    Deng, G. C.
    Guan, S. S.
    Yan, H.
    Han, Q. L.
    Yao, L.
    Sun, D. C.
    Dai, G. H.
    PANCREAS, 2019, 48 (10) : 1420 - 1420
  • [4] A phase Ⅱ trial of oxaliplatin plus S-1 as a first-line chemotherapy for patients with advanced gastric cancer
    YANG Lin
    SONG Yan
    ZHOU Ai-ping
    QIN Qiong
    CHI Yihebali
    HUANG Jing
    WANG Jin-wan
    中华医学杂志（英文版）, 2013, 126 (18) : 3470 - 3474
  • [5] Gemcitabine plus paclitaxel as first-line chemotherapy for patients with advanced breast cancer
    Delfino, C
    Caccia, G
    Gonzáles, LR
    Mickiewicz, E
    Rodger, J
    Balbiani, L
    Morales, DF
    Comba, AZ
    Brosio, C
    ONCOLOGY, 2004, 66 (01) : 18 - 23
  • [6] Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine as first-line chemotherapy in patients with advanced pancreatic ductal adenocarcinoma: a randomized study
    Zong, Yuan
    Yuan, Jiajia
    Peng, Zhi
    Lu, Ming
    Wang, Xicheng
    Shen, Lin
    Zhou, Jun
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (05) : 1529 - 1536
  • [7] Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine as first-line chemotherapy in patients with advanced pancreatic ductal adenocarcinoma: a randomized study
    Yuan Zong
    Jiajia Yuan
    Zhi Peng
    Ming Lu
    Xicheng Wang
    Lin Shen
    Jun Zhou
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 1529 - 1536
  • [8] A phase II trial of oxaliplatin plus S-1 as a first-line chemotherapy for patients with advanced gastric cancer
    Yang Lin
    Song Yan
    Zhou Ai-ping
    Qin Qiong
    Chi Yihebali
    Huang Jing
    Wang Jin-wan
    CHINESE MEDICAL JOURNAL, 2013, 126 (18) : 3470 - 3474
  • [9] Docetexal plus S-1 Versus Oxaliplatin plus S-1 for First-Line Treatment of Patients with Advanced Gastric Cancer: A Retrospective Study
    Wang, Mei
    Wu, Meihong
    Wang, Wei
    Wang, Qingshui
    Wang, Yajie
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 (1-2) : 24 - 28
  • [10] A phase I/II study of nanoliposomal irinotecan plus S-1 in metastatic pancreatic cancer after first-line gemcitabine-based chemotherapy
    Imaoka, H.
    Sasaki, M.
    Ueno, M.
    Ozaka, M.
    Kobayashi, S.
    Fukushima, T.
    Furukawa, T.
    Ikeda, M.
    ANNALS OF ONCOLOGY, 2022, 33 : S1484 - S1484
12345